ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,387,644 | -13.7% | 2,161,401 | -2.2% | 0.00% | – |
| Q2 2023 | $5,081,388 | -18.9% | 2,209,299 | +6.8% | 0.00% | – |
| Q1 2023 | $6,266,198 | -33.6% | 2,068,052 | -48.9% | 0.00% | – |
| Q4 2022 | $9,436,808 | +145.6% | 4,050,132 | +101.4% | 0.00% | – |
| Q3 2022 | $3,842,000 | -27.6% | 2,011,376 | +2.7% | 0.00% | – |
| Q2 2022 | $5,309,000 | +0.4% | 1,958,920 | +10.4% | 0.00% | – |
| Q1 2022 | $5,289,000 | -19.3% | 1,774,936 | +5.4% | 0.00% | – |
| Q4 2021 | $6,550,000 | -7.8% | 1,683,829 | +1.7% | 0.00% | – |
| Q3 2021 | $7,106,000 | +102.9% | 1,656,383 | +43.3% | 0.00% | – |
| Q2 2021 | $3,503,000 | +1753.4% | 1,156,094 | +1942.2% | 0.00% | – |
| Q1 2021 | $189,000 | -6.0% | 56,610 | 0.0% | 0.00% | – |
| Q4 2020 | $201,000 | +24.1% | 56,610 | +9.1% | 0.00% | – |
| Q3 2020 | $162,000 | +1250.0% | 51,910 | +344.2% | 0.00% | – |
| Q1 2020 | $12,000 | -62.5% | 11,686 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | +77.8% | 11,686 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -80.0% | 11,686 | -73.1% | 0.00% | – |
| Q2 2019 | $90,000 | -95.6% | 43,479 | -92.4% | 0.00% | – |
| Q1 2019 | $2,057,000 | -10.2% | 574,476 | -3.9% | 0.00% | – |
| Q4 2018 | $2,290,000 | -58.5% | 597,932 | +2.5% | 0.00% | – |
| Q3 2018 | $5,513,000 | +51.4% | 583,214 | +16.9% | 0.00% | – |
| Q2 2018 | $3,642,000 | +5178.3% | 499,079 | +3527.0% | 0.00% | – |
| Q1 2018 | $69,000 | +4.5% | 13,760 | +5.8% | 0.00% | – |
| Q4 2017 | $66,000 | -20.5% | 13,000 | -2.1% | 0.00% | – |
| Q3 2017 | $83,000 | +76.6% | 13,281 | +1.2% | 0.00% | – |
| Q2 2017 | $47,000 | +14.6% | 13,125 | +2.5% | 0.00% | – |
| Q1 2017 | $41,000 | +36.7% | 12,810 | +4.1% | 0.00% | – |
| Q4 2016 | $30,000 | -25.0% | 12,300 | +4.3% | 0.00% | – |
| Q3 2016 | $40,000 | -7.0% | 11,790 | -5.4% | 0.00% | – |
| Q2 2016 | $43,000 | -14.0% | 12,469 | +3.9% | 0.00% | – |
| Q1 2016 | $50,000 | -12.3% | 12,001 | -5.6% | 0.00% | – |
| Q4 2015 | $57,000 | -72.6% | 12,715 | -62.9% | 0.00% | – |
| Q3 2015 | $208,000 | – | 34,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |